At the DOH Kapihan Wednesday, Dr.

Mario Jiz of the Research Institute for Tropical

Medicine cited a study conducted by a US-based laboratory showing that non-human
primates were boosted with the original dose and the Omicron-specific dose.

Data showed that the neutralizing antibodies of those vaccinated with the original
dose had an increase of 2,980 against Omicron two weeks after receiving the booster
shot.

Meanwhile, the antibodies of those given the Omicron-specific booster rose to 1,930
after two weeks.

"Collectively, the data showed that boosting with either the same homologous
Moderna vaccine that we are currently providing to everybody right now or the
exploratory Omicron-variant vaccine, they both lead to comparable and significant
increases in neutralizing antibody responses against all variants of concern, including
Omicron," Jiz said.